NASDAQ:MBOT Microbot Medical (MBOT) Stock Price, News & Analysis $1.36 -0.06 (-4.23%) Closing price 09/18/2026 04:00 PM EasternExtended Trading$1.38 +0.01 (+1.10%) As of 09/18/2026 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsNews and TrendsOptions ChainOwnershipSEC Filings About Microbot Medical Stock (NASDAQ:MBOT) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Microbot Medical alerts:Sign Up Key Stats Today's Range$1.35▼$1.4350-Day Range$1.36▼$1.9452-Week Range$1.35▼$3.74Volume686,319 shsAverage Volume443,395 shsMarket Capitalization$91.35 millionP/E RatioN/ADividend YieldN/APrice Target$6.38Consensus RatingHold Company Overview Microbot Medical Inc. is a medical-device company focused on developing robotic and computer-assisted technologies for minimally invasive vascular procedures. The company’s primary product candidate is the LIBERTY Endovascular Robotic System, a compact, single-use system designed to enable physicians to remotely control the navigation and positioning of guidewires and catheters during endovascular interventions. LIBERTY is intended to support procedures involving the peripheral and coronary vasculature while potentially reducing physician exposure to radiation and improving procedural control. Microbot Medical has described the system as a disposable platform designed to integrate into existing catheterization laboratories without requiring a large capital installation. The company continues to pursue regulatory and commercial development of its technology, and product availability is subject to applicable regulatory clearances. Microbot Medical was established in Israel and conducts its research and development activities there, while pursuing opportunities in the United States and other international markets. The company is led by Harel Gadot, who serves as chairman, president and chief executive officer. Its shares trade on the Nasdaq Capital Market under the symbol MBOT.AI Generated. May Contain Errors. Read More Microbot Medical Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks42nd Percentile Overall ScoreMBOT MarketRank™: Microbot Medical scored higher than 42% of companies evaluated by MarketBeat, and ranked 602nd out of 897 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion4.0 / 5Analyst RatingHold Consensus RatingMicrobot Medical has received a consensus rating of Hold. The company's average rating score is 2.40, and is based on no strong buy ratings, 3 buy ratings, 1 hold rating, and 1 sell rating.Upside PotentialMicrobot Medical has a consensus price target of $6.38, representing about 368.8% upside from its current price of $1.36.Amount of Analyst CoverageMicrobot Medical has only been the subject of 4 research reports in the past 90 days.Read more about Microbot Medical's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Microbot Medical are expected to grow in the coming year, from ($0.30) to ($0.27) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Microbot Medical is -5.67, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Microbot Medical is -5.67, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioMicrobot Medical has a P/B Ratio of 1.18. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Microbot Medical's valuation and earnings. Short Interest0.0 / 5Short Interest LevelBearish Percentage of Shares Shorted11.30% of the float of Microbot Medical has been sold short.Short Interest Ratio / Days to CoverMicrobot Medical has a short interest ratio ("days to cover") of 10.11, which indicates bearish sentiment.Change versus previous monthShort interest in Microbot Medical has recently increased by 0.64%, indicating that investor sentiment is decreasing. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldMicrobot Medical does not currently pay a dividend.Dividend GrowthMicrobot Medical does not have a long track record of dividend growth. News and Social Media2.8 / 5News Sentiment0.45 News SentimentMicrobot Medical has a news sentiment score of 0.45. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.56 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Microbot Medical this week, compared to 2 articles on an average week.Search Interest4 people have searched for MBOT on MarketBeat in the last 30 days. This is an increase of 33% compared to the previous 30 days.MarketBeat FollowsOnly 5 people have added Microbot Medical to their MarketBeat watchlist in the last 30 days. This is a decrease of -58% compared to the previous 30 days. Company Ownership0.4 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Microbot Medical insiders have not sold or bought any company stock.Percentage Held by Insiders4.74% of the stock of Microbot Medical is held by insiders.Percentage Held by Institutions16.30% of the stock of Microbot Medical is held by institutions.Read more about Microbot Medical's insider trading history. Receive MBOT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Microbot Medical and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. MBOT Stock News HeadlinesMicrobot Medical (NASDAQ:MBOT) Raised to "Sell" at Wall Street ZenSeptember 19 at 1:30 AM | americanbankingnews.comB. Riley Financial Begins Coverage on Microbot Medical (NASDAQ:MBOT)September 13, 2026 | americanbankingnews.com“Elon’s nightmare” could fund your retirementMarc Chaikin, the 60 year Wall Street veteran whose Chaikin Money Flow indicator sits on every Bloomberg terminal, says a new micro cluster AI technology could render today's data centers, including Elon Musk's Colossus in Tennessee, obsolete for major breakthroughs. These next generation centers use 99 percent less space, electricity and water, yet Chaikin's research shows they could be more than a trillion times more powerful than the top data center on earth today, potentially cutting AI breakthrough timelines from five years to five days. | Chaikin Analytics (Ad)Microbot Medical Inc.: Microbot Medical Files 10-Q, Reports Significant Revenue and Customer Growth During the 2026 Second QuarterAugust 11, 2026 | finanznachrichten.deMicrobot Medical® Files 10-Q, Reports Significant Revenue and Customer Growth During the 2026 Second QuarterAugust 11, 2026 | markets.businessinsider.comMicrobot Medical to Present on Endovascular Robotics at Society of Robotic Surgery Annual MeetingJuly 21, 2026 | quiverquant.comQMicrobot Medical® Among Featured Companies Showcasing Novel Robotic Technologies and Digital Surgery Applications at the Society of Robotic Surgery Annual MeetingJuly 21, 2026 | globenewswire.comMicrobot Medical® Reports Over 100% Revenue and Customer Growth as Procedure Volume Also Rises in the Second Quarter of 2026July 7, 2026 | globenewswire.comSee More Headlines MBOT Stock Analysis - Frequently Asked Questions How have MBOT shares performed this year? Microbot Medical's stock was trading at $2.00 at the beginning of the year. Since then, MBOT shares have decreased by 32.0% and is now trading at $1.36. How were Microbot Medical's earnings last quarter? Microbot Medical Inc. (NASDAQ:MBOT) posted its quarterly earnings results on Tuesday, August, 11th. The biotechnology company reported ($0.08) earnings per share for the quarter, missing the consensus estimate of ($0.08) by $0.00. The biotechnology company earned $0.24 million during the quarter, compared to analyst estimates of $0.13 million. When did Microbot Medical's stock split? Microbot Medical shares reverse split on the morning of Monday, May 9th 2016.The 1-12 reverse split was announced on Friday, May 6th 2016. The number of shares owned by shareholders was adjusted after the closing bell on Friday, May 6th 2016. An investor that had 100 shares of stock prior to the reverse split would have 8 shares after the split. Who are Microbot Medical's major shareholders? Top institutional shareholders of Microbot Medical include Squarepoint Ops LLC (0.03%). View institutional ownership trends. How do I buy shares of Microbot Medical? Shares of MBOT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Microbot Medical own? Based on aggregate information from My MarketBeat watchlists, some other companies that Microbot Medical investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), Meta Platforms (META), TransEnterix (TRXDW), Pfizer (PFE), Plug Power (PLUG) and Novavax (NVAX). Company Calendar Last Earnings8/11/2026Today9/19/2026Next Earnings (Estimated)11/11/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (1m+) 1-Year History Sep 25 Dec 25 Mar 26 Jun 26 Sep 26 MBOT's financial health is in the Red zone, according to TradeSmith. MBOT has been in this zone for over one month. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Equipment Current SymbolNASDAQ:MBOT CIK883975 Webwww.microbotmedical.com Phone(908) 938-5561Fax781-556-5347Employees22Year Founded2010Price Target and Rating Average Price Target for Microbot Medical$6.38 High Price Target$12.00 Low Price Target$4.00 Potential Upside/Downside+368.8%Consensus RatingHold Rating Score (0-4)2.40 Research Coverage5 Analysts Profitability EPS (Trailing Twelve Months)($0.24) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$13.14 million Net MarginsN/A Pretax Margin-4,722.25% Return on Equity-21.87% Return on Assets-20.76% Debt Debt-to-Equity RatioN/A Current Ratio18.56 Quick Ratio17.82 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$1.15 per share Price / Book1.18Miscellaneous Outstanding Shares67,170,000Free Float63,981,000Market Cap$91.35 million OptionableOptionable Beta1.03 Social Links The 10 Best High-Yield Dividend Stocks for 2026Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free Report This page (NASDAQ:MBOT) was last updated on 9/20/2026 by MarketBeat.com Staff. From Our Partners$40,000,000,000,000The national debt just hit 40 trillion dollars, and the U.S. now spends more on interest payments than on its ...American Alternative | Sponsored“Elon’s nightmare” could fund your retirementMarc Chaikin, the 60 year Wall Street veteran whose Chaikin Money Flow indicator sits on every Bloomberg termi...Chaikin Analytics | SponsoredYou’ve never seen anything like this beforeFor centuries, families like the Rothschilds, Morgans, and Rockefellers have quietly used one overlooked type ...Porter & Company | SponsoredBank of America: 'Digital Dollar Inevitable'Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...Decentralized Masters | SponsoredMy top 3 AI picks for the next decadeAlexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...The Oxford Club | SponsoredTrump goes "all-in" on Grand Canyon energy breakthroughA drilling crew near the Grand Canyon uncovered a clean energy well producing nearly eight times the output of...Behind the Markets | SponsoredA “bloodbath” Is ComingReports suggest some Silicon Valley billionaires are stockpiling gold, guns, and gas masks - or leaving the co...TradeSmith | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Microbot Medical Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Microbot Medical With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
